Next Article in Journal
XOR Binary Gravitational Search Algorithm with Repository: Industry 4.0 Applications
Next Article in Special Issue
The Oral Microbiome in Children with Black Stained Tooth
Previous Article in Journal
Tonic and Phasic Amperometric Monitoring of Dopamine Using Microelectrode Arrays in Rat Striatum
Previous Article in Special Issue
Oral Microbiome in Four Female Centenarians
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Oral Microbiome of Healthy Japanese People at the Age of 90

1
Department of Translational Research, Tsurumi University School of Dental Medicine, Kanagawa 230-8501, Japan
2
Department of Oral bacteriology, Tsurumi University School of Dental Medicine, Kanagawa 230-8501, Japan
3
Division of Preventive Dentistry, Faculty of Dentistry and Graduate School of Medical and Dental Science, Niigata University, Niigata 951-8514, Japan
4
Division of Oral Science for Health Promotion, Faculty of Dentistry and Graduate School of Medical and Dental Science, Niigata University, Niigata 951-8514, Japan
*
Author to whom correspondence should be addressed.
Appl. Sci. 2020, 10(18), 6450; https://doi.org/10.3390/app10186450
Submission received: 19 August 2020 / Revised: 15 September 2020 / Accepted: 15 September 2020 / Published: 16 September 2020
(This article belongs to the Special Issue Oral Microbial Communities and Oral Health)

Abstract

:
For a healthy oral cavity, maintaining a healthy microbiome is essential. However, data on healthy microbiomes are not sufficient. To determine the nature of the core microbiome, the oral-microbiome structure was analyzed using pyrosequencing data. Saliva samples were obtained from healthy 90-year-old participants who attended the 20-year follow-up Niigata cohort study. A total of 85 people participated in the health checkups. The study population consisted of 40 male and 45 female participants. Stimulated saliva samples were obtained by chewing paraffin wax for 5 min. The V3–V4 hypervariable regions of the 16S ribosomal RNA (rRNA) gene were amplified by PCR. Pyrosequencing was performed using MiSeq. Operational taxonomic units (OTUs) were assigned on the basis of a 97% identity search in the EzTaxon-e database. Using the threshold of 100% detection on the species level, 13 species were detected: Streptococcus sinensis, Streptococcus pneumoniae, Streptococcus salivarius, KV831974_s, Streptococcus parasanguinis, Veillonella dispar, Granulicatella adiacens, Streptococcus_uc, Streptococcus peroris, KE952139_s, Veillonella parvula, Atopobium parvulum, and AFQU_vs. These species represent potential candidates for the core make-up of the human microbiome.

1. Introduction

Microbiota inhabiting the human body have long been recognized as critical for a variety of human diseases and in maintaining human health [1,2,3,4,5]. The microbiome of humans has been extensively studied using accurate and efficient approaches involving high-throughput sequencing technologies and bioinformatics [6].
Among several microbiomes in the human body, the oral microbiome has been extensively studied. Specific bacterial taxa are responsible for oral infectious diseases, such as dental caries and periodontal diseases. Microbial diversity increases in parallel with the progression of periodontitis [7]. Several studies showed that there is a relationship between the human oral microbiome and certain systemic diseases, such as pancreatic cancer [8], Type 2 diabetes [9], pediatric Crohn’s disease [10], heart disease [11], and low-weight preterm birth [12]. Certain oral bacterial species may contribute to carcinogenesis [13]. The role of the oral microbiome involves the mediation of inflammation related to changes in systemic health and disease [14].
In addition to these intensive studies related to disease, health-associated species in the oral cavity have been identified. One of the primary goals of the Human Microbiome Project [15] launched by the National Institutes of Health was to characterize the core microbiome. The concept of the core human oral microbiome involves comprehensive, minimal bacteria that regularly inhabit the human body. The human core microbiome is hypothesized to be important for development, health, and functioning. Some diseases, including autoimmune disorders [16], diabetes, and obesity [17,18], are caused by perturbation of the core gut microbiome. Therefore, a beneficial oral microbiome and its associated ecosystem functions may ensure host health and wellbeing [19,20,21].
The aims of this study were to determine if a healthy core microbiome is meaningful in the context of disease prevention and to investigate whether the microbiome of healthy older people may be a suitable representation of a healthy microbiome. Data on the oral microbiome of healthy older people may be useful for a comparison with the microbiome of subjects with specific diseases in an effort to determine if their etiology is related to an imbalance of the microbiome or colonization by specific bacterial taxa. These data may be useful for the development of a healthy core microbiome from a young age. Several studies have investigated the oral microbiome of older people. These studies were focused on the etiology of diseases or disease conditions [22,23,24,25,26,27,28,29,30,31]. Few studies investigating healthy older people are available [32,33,34].
The aim of this study was to investigate the oral microbiome of a community of healthy people at the age of 90 in an attempt to identify their core oral microbiome.

2. Materials and Methods

2.1. Study Design, Setting, and Participants

The subjects that participated in this study were sourced from the Niigata study, a community-based cohort study investigating the relationship between oral health and systemic health in older subjects aged 70 in 2008. Sampling and data collection procedures were described in previous reports in detail [35,36]. A 20-year follow-up study was conducted in 2018 through mass examination. Dental and medical examinations were carried out. Briefly, all of our cohorts did not present with any comorbidities.

2.2. Sampling and Microbial DNA Extraction

Saliva samples were collected by chewing paraffin wax for 5 min. Collected samples were kept on ice. Upon transporting them to the laboratory, samples were frozen at −20 °C until DNA extraction. Saliva samples were centrifuged at 3000 rpm for 10 min. The Maxwell 16 LEV Blood DNA Kit (Promega KK, Tokyo, Japan) was used for DNA extraction. The NanoDrop ND-2000 (Thermo Fisher Scientific KK, Tokyo, Japan) was used for the measurement of DNA concentration. DNA degradation was visually checked by electrophoresis on a 1% agarose gel using the Qubit dsDNA BR Assay Kit (Thermo Fisher Scientific KK, Tokyo, Japan). The inclusion criteria for DNA samples subjected to further analysis were as follows: concentration > 20 ng/μL, volume ≥ 20 μL, A260/280 ≥ 1.8, and A260/230 >1.5 [32,37].

2.3. Microbial-Community Analysis

A polymerase chain reaction (PCR) was carried out using primers specific to the V3–V4 region involving pyrosequencing tags of the 16S ribosomal RNA (rRNA) gene. The taxonomic classification of each read was assigned on the basis of a search of the EzBioCloud 16S database [38,39]. By applying the data from this database, a hierarchical taxonomic classification was obtained [32,37]. These analyses were carried out by Chun Lab (Seoul, Korea).

2.4. Bioinformatics Analysis

The relative abundance of the 16S rRNA gene for each operational taxonomic unit (OTU) was used to determine the absolute abundance of each OTU by multiplying the respective relative abundance by the total number of 16S rRNA gene copies. The Microbiome and Phyloseq packages in R software version 3.50 (Lucent Technologies, Murray Hill, NJ, USA) were used for analysis [40]. Heatmaps and core heatmaps [41] were used for visualization. Core line-plot and t-distributed stochastic neighbor embedding (t-SNE) [42] analyses were performed using the Microbiome Rtsne and Vegan packages.

2.5. Ethics Approval

All subjects who participated in this study were approved for the purpose of this study. Prior to saliva collection, they completed an informed-consent form. This study was approved by the Ethics Committee of the Tsurumi University School of Dental Medicine (Approval Number: 1332).

3. Results

3.1. Study Participants

The number of subjects participating in this study was 87. There were 41 men and 46 women who were all 90 years old. Adequate mount samples for pyrosequencing analysis were not obtained from one man and one woman.

3.2. Sequence Data

From the 85 subjects, 3,899,271 reads (minimum, 23,272; maximum, 108,597) passed quality control. From these reads, sequences were clustered into 24 phyla, 48 classes, 106 orders, 214 families, 529 genera, and 1216 species. The prevalence and abundances of all 1216 species are visualized using a heatmap in Figure S1 (Supplementary Materials).
The summary statistics of the alpha diversity indices are shown in Table S1 (Supplementary Materials). The rarefaction curve is presented in Figure S2 (Supplementary Materials).

3.3. Oral-Microbiome Structure

Figure 1 shows the relative abundance of detected bacteria. Data are presented separately on the (A) phylum and (B) genus levels. The Firmicutes phylum was most abundant, followed by Actinobacteria and Bacteroides. The abundance of these phyla constituted 92.6% of the sample. On the genus level, Streptococcus represented 44.5%, Rothia represented 15.2%, and Veillonella represented 9.0% of the sample. The composition bar plots for each sample on the phylum level are shown in Figure S3 (Supplementary Materials). The proportional ranges of these bacteria were 42.7% to 93.0% for Firmicutes, 4.7% to 39.8% for Actinobacteria, and <0.01% to 39.6% for Bacteroides. Taxon prevalence is shown in Figure 2. The prevalence of each species is plotted against their abundance. Highly prevalent phyla were Firmicutes and Actinobacteria. The core line plot is shown in Figure S4 (Supplementary Materials).

3.4. Candidates for Core Microbiome and Core-Microbiome Analysis

Table 1 shows the bacterial species detected in more than 90% of subjects. Thirteen species were detected in all subjects. Among these 13 species, eight species were from the Streptococcus genus. These species represent potential candidates for the core oral microbiome. These 13 species are visualized using a phylogenetic tree and core heatmap in Figure 3.
According to Figure 3, eight species of Streptococcus were not adjacent. Streptococcus sinensis and Streptococcus pneumoniae were highly prevalent and abundant species.

3.5. Ordination Analysis

The t-SNE plot allows embedding high-dimensional data into a two-dimensional map on the basis of each data point. Each species was categorized according to its prevalence (Figure 4A) or genus (Figure 4B). Through this graphical observation, highly prevalent species were conglomerated, and low-prevalence species were separated into distinct groups. Species were not separated on the basis of their genus. These results indicate that, on the species level, oral bacteria formed groups, and their coexistence was not regulated by their genus.

4. Discussion

In this study, we investigated 85 healthy people at the age of 90, focusing on analyzing their core oral microbiome. On the basis of the pyrosequencing analysis, 389,927 valid reads were obtained, and 1216 species were detected. Thirteen species were detected in all 85 subjects. Among them, seven belonged to the Streptococcus genus. These species represent potential candidates for the core human oral microbiome.
In this study, the most abundant phylum was Firmicutes, whereas Streptococcus constituted 45% of the genera present. The microbiome structure on the phylum level was categorized as follows: Firmicutes (62.7%), Bacteroides (9.6%), Proteobacteria (3.8%), Fusobacteria (2.7%), and Actinobacteria (20.3%). A previous study investigating subjects aged 60 years and older in China showed that the abundant phyla were Firmicutes (29.6%), Bacteroides (22.4%), Proteobacteria (20.4%), Fusobacteria (16.2%), and Actinobacteria (7.6%) [43]. Another study showed that the core oral microbiome predominantly comprises Firmicutes, followed by Proteobacteria and Bacteroides [44]. Firmicutes, Proteobacteria, Bacteroides, Fusobacteria, and Actinobacteria constitute more than 98% of the oral microbiome [45]. The oral-microbiome structure may change as a function of growth [46], food [47,48], oral diseases [49,50,51], or infection [51,52]. These results are consistent with the results of this study.
Few reports presented the core microbiome on the genus or species level. On the genus level, Neisseria (12.5%), Leptotrichia (11.1%), Streptococcus (10.7%), Prevotella (7.0%), Veillonella (6.9%), Fusobacterium (5.4%), Capnocytophaga (4.2%), Prevotella (4.1%), Corynebacterium (2.6%), Saccharibacteria (2.6%), Actinomyces (2.6%), Haemophilus (2.3%), and Porphyromonas (2.2%) were most prevalent [43]. Abundant genera according to another study were Streptococcus (26.1%), Veillonella (21.9%), Neisseria (16.9%), Haemophilus (10.7%), Actinomycetes (2.6%), Rothia (3.1%), and Oribacterium (1.7%) [53]. On the species level, a study carried out in Japan identified Streptococcus salivarius (9.5%), Prevotella melaninogenica (9.2%), Rothia mucilaginosa (8.8%), Veillonella atypica (6.0%), and Neisseria flavescens (5.8%) as species exhibiting > 5% abundance on the tongue surface [34]. When compared with our results, shown in Table 1, four of these species were detected in all our subjects, except for Neisseria flavescens. Neisseria sp. is often detected in samples obtained from the dorsal surface of the tongue [54]. On the phylum level, the core microbiome observed in our study coincided with that in the literature. However, on the genus or species level, predominant bacteria varied across studies.
There are environmental and cultural differences, such as food consumption, that affect microbiome structure [49,55,56,57]; in our study, the proportions of Firmicutes and Streptococcus were higher than those found in other studies.
Streptococcus spp. are abundant in human milk, and they play an important role in the establishment of the oral-microbiome structure for breastfed infants [58,59]. Some Streptococcus spp. act as probiotic bacteria [60,61]. In contrast to these beneficial effects of Streptococcus for the human body, pathogenic Streptococcus sinensis, which is responsible for bacteremia [62] and endocarditis [63], and Streptococcus pneumoniae [64] were detected in all samples.
Two species of Veillonella, which are also classified as Firmicutes, were detected in all samples. Veillonella is known to be prevalently detected at various sites in the oral cavity, such as dental plaque, saliva [65], and oral mucosa [66]. Veillonella parvula is associated with the development of dental caries [67], endodontic infections [68], and periodontitis [69]. The most abundant species in our study was Streptococcus sinensis, followed by Streptococcus pneumoniae.
In this study, Fusobacterium nucleatum was detected in 94.1% of subjects. A previous study showed that Fusobacteria represent a predominant taxon in the oral microbiome [69]. Fusobacteria mediate the coaggregation of nonaggregating microbiota, and they are a structural element of plaque in both healthy and disease conditions [70]. They may contribute to the diversity of the oral microbiome.
A pioneering study of the oral microbiome using pyrosequencing suggested that the concept of a healthy core microbiome was supported by abundant oral taxa found in the oral cavity of healthy individuals [66,71]. Phylogenetic trees of 118 of the most predominant taxa identified at several sampling sites in the oral cavity were presented [71]. Among the 13 species detected in all subjects, five species were not included in this phylogenetic tree. These 13 species included pathogenic bacteria leading to human diseases. These bacteria were also detected in healthy older persons; however, they are not proposed as candidates for a healthy core oral microbiome.
It has been suggested that periodontal disease can be a major risk factor for some systemic diseases [72,73,74,75,76,77]. Recent advances in research on oral and general health have shown that there are protective host factors for periodontal-related systemic diseases [78,79,80]. The limitation of this study is its cross-sectional study. Further study is necessary to investigate the oral microbiome that can be the risk for mortality in combination with these host factors for older people.
In this study, we aimed to identify the core oral microbiome in healthy older people. However, on the basis of prevalence and abundance, pathogenic bacteria were also included. The human oral microbiome plays a crucial role in diseases and human health. Simple descriptive analysis as a function of prevalence and abundance may not be enough to define a healthy core microbiome. The effect of bacteria should be considered when defining a healthy human oral microbiome.

Supplementary Materials

The following are available online at https://www.mdpi.com/2076-3417/10/18/6450/s1. Figure S1. Heatmap of 1216 species detected in this study; Figure S2. Rarefaction curves of the 85 subjects; Figure S3. Composition bar plots for each subject at the phylum level; Figure S4. Core line plot; Table S1. Alpha diversity indices.

Author Contributions

Conceptualization, Y.N., A.Y., and N.H.; methodology, Y.N. and A.Y.; formal analysis, Y.N.; investigation, Y.N., E.K., and M.O.; resources, N.K.; writing—original-draft preparation, Y.N.; writing—review and editing, Y.N.; visualization, Y.N.; project administration, K.N.; funding acquisition, Y.N. and N.H. All authors read and agreed to the published version of the manuscript.

Funding

This study was supported by the JSPS KAKENHI (grant numbers 17K12030 and 20K10303) and the SECOM Science and Technology Foundation. The funders played no role in the design of the study, in data collection, in the analysis and interpretation of the results, or in the writing of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Lynch, S.V.; Pedersen, O. The Human Intestinal Microbiome in Health and Disease. N. Engl. J. Med. 2016, 375, 2369–2379. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Silbergeld, E.K. The Microbiome. Toxicol. Pathol. 2017, 45, 190–194. [Google Scholar] [CrossRef] [PubMed]
  3. Tuddenham, S.; Sears, C.L. The intestinal microbiome and health. Curr. Opin. Infect. Dis. 2015, 28, 464–470. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Singh, R.K.; Chang, H.W.; Yan, D.; Lee, K.M.; Ucmak, D.; Wong, K.; Abrouk, M.; Farahnik, B.; Nakamura, M.; Zhu, T.H.; et al. Influence of diet on the gut microbiome and implications for human health. J. Transl. Med. 2017, 15, 73. [Google Scholar] [CrossRef] [Green Version]
  5. Rinninella, E.; Raoul, P.; Cintoni, M.; Franceschi, F.; Miggiano, G.A.D.; Gasbarrini, A.; Mele, M.C. What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms 2019, 7, 14. [Google Scholar] [CrossRef] [Green Version]
  6. Schwartz, M.H.; Wang, H.; Pan, J.N.; Clark, W.C.; Cui, S.; Eckwahl, M.J.; Pan, D.W.; Parisien, M.; Owens, S.M.; Cheng, B.L.; et al. Microbiome characterization by high-throughput transfer RNA sequencing and modification analysis. Nat. Commun. 2018, 9, 5353. [Google Scholar] [CrossRef]
  7. Papapanou, P.N.; Park, H.; Cheng, B.; Kokaras, A.; Paster, B.; Burkett, S.; Watson, C.W.; Annavajhala, M.K.; Uhlemann, A.C.; Noble, J.M. Subgingival microbiome and clinical periodontal status in an elderly cohort: The WHICAP ancillary study of oral health. J. Periodontol. 2020. [Google Scholar] [CrossRef]
  8. Farrell, J.J.; Zhang, L.; Zhou, H.; Chia, D.; Elashoff, D.; Akin, D.; Paster, B.J.; Joshipura, K.; Wong, D.T. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 2012, 61, 582–588. [Google Scholar] [CrossRef]
  9. Demmer, R.T.; Jacobs, D.R., Jr.; Singh, R.; Zuk, A.; Rosenbaum, M.; Papapanou, P.N.; Desvarieux, M. Periodontal Bacteria and Prediabetes Prevalence in ORIGINS: The Oral Infections, Glucose Intolerance, and Insulin Resistance Study. J. Dent. Res. 2015, 94, 201S–211S. [Google Scholar] [CrossRef] [Green Version]
  10. Docktor, M.J.; Paster, B.J.; Abramowicz, S.; Ingram, J.; Wang, Y.E.; Correll, M.; Jiang, H.; Cotton, S.L.; Kokaras, A.S.; Bousvaros, A. Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease. Inflamm. Bowel Dis. 2012, 18, 935–942. [Google Scholar] [CrossRef]
  11. Liu, X.R.; Xu, Q.; Xiao, J.; Deng, Y.M.; Tang, Z.H.; Tang, Y.L.; Liu, L.S. Role of oral microbiota in atherosclerosis. Clin. Chim. Acta 2020, 506, 191–195. [Google Scholar] [CrossRef] [PubMed]
  12. Cobb, C.M.; Kelly, P.J.; Williams, K.B.; Babbar, S.; Angolkar, M.; Derman, R.J. The oral microbiome and adverse pregnancy outcomes. Int. J. Womens Health 2017, 9, 551–559. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Teles, F.R.F.; Alawi, F.; Castilho, R.M.; Wang, Y. Association or Causation? Exploring the Oral Microbiome and Cancer Links. J. Dent. Res. 2020. [Google Scholar] [CrossRef] [PubMed]
  14. Kleinstein, S.E.; Nelson, K.E.; Freire, M. Inflammatory Networks Linking Oral Microbiome with Systemic Health and Disease. J. Dent. Res. 2020, 99, 1131–1139. [Google Scholar] [CrossRef] [PubMed]
  15. Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project. Nature 2019, 569, 641–648. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Severance, E.G.; Yolken, R.H.; Eaton, W.W. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: More than a gut feeling. Schizophr. Res. 2016, 176, 23–35. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Barengolts, E.; Green, S.J.; Chlipala, G.E.; Layden, B.T.; Eisenberg, Y.; Priyadarshini, M.; Dugas, L.R. Predictors of Obesity among Gut Microbiota Biomarkers in African American Men with and without Diabetes. Microorganisms 2019, 7, 320. [Google Scholar] [CrossRef] [Green Version]
  18. Zhang, F.; Wang, M.; Yang, J.; Xu, Q.; Liang, C.; Chen, B.; Zhang, J.; Yang, Y.; Wang, H.; Shang, Y.; et al. Response of gut microbiota in type 2 diabetes to hypoglycemic agents. Endocrine 2019, 66, 485–493. [Google Scholar] [CrossRef]
  19. Ulloa, C.P.; van der Veen, M.H.; Krom, B.P. Review: Modulation of the oral microbiome by the host to promote ecological balance. Odontology 2019, 107, 437–448. [Google Scholar] [CrossRef] [Green Version]
  20. Marsh, P.D. In Sickness and in Health-What Does the Oral Microbiome Mean to Us? An Ecological Perspective. Adv. Dent. Res. 2018, 29, 60–65. [Google Scholar] [CrossRef]
  21. Rosier, B.T.; Marsh, P.D.; Mira, A. Resilience of the Oral Microbiota in Health: Mechanisms That Prevent Dysbiosis. J. Dent. Res. 2018, 97, 371–380. [Google Scholar] [CrossRef] [PubMed]
  22. Tam, J.; Hoffmann, T.; Fischer, S.; Bornstein, S.; Gräßler, J.; Noack, B. Obesity alters composition and diversity of the oral microbiota in patients with type 2 diabetes mellitus independently of glycemic control. PLoS ONE 2018, 13, e0204724. [Google Scholar] [CrossRef]
  23. Abe, K.; Takahashi, A.; Fujita, M.; Imaizumi, H.; Hayashi, M.; Okai, K.; Ohira, H. Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease. PLoS ONE 2018, 13, e0198757. [Google Scholar] [CrossRef] [PubMed]
  24. Gaetti-Jardim, E., Jr.; Jardim, E.C.; Schweitzer, C.M.; da Silva, J.C.; Oliveira, M.M.; Masocatto, D.C.; dos Santos, C.M. Supragingival and subgingival microbiota from patients with poor oral hygiene submitted to radiotherapy for head and neck cancer treatment. Arch. Oral Biol. 2018, 90, 45–52. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Si, J.; Lee, C.; Ko, G. Oral Microbiota: Microbial Biomarkers of Metabolic Syndrome Independent of Host Genetic Factors. Front. Cell. Infect. Microbiol. 2017, 7, 516. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Ogawa, T.; Ogawa, H.M.; Ikebe, K.; Notomi, Y.; Iwamoto, Y.; Shirobayashi, I.; Hata, S.; Kibi, M.; Masayasu, S.; Sasaki, S.; et al. Characterizations of oral microbiota in elderly nursing home residents with diabetes. J. Oral Sci. 2017, 59, 549–555. [Google Scholar] [CrossRef] [Green Version]
  27. Flemer, B.; Warren, R.D.; Barrett, M.P.; Cisek, K.; Das, A.; Jeffery, I.B.; Hurley, E.; O’Riordain, M.; Shanahan, F.; O’Toole, P.W. The oral microbiota in colorectal cancer is distinctive and predictive. Gut 2018, 67, 1454–1463. [Google Scholar] [CrossRef]
  28. Olson, S.H.; Satagopan, J.; Xu, Y.; Ling, L.; Leong, S.; Orlow, I.; Saldia, A.; Li, P.; Nunes, P.; Madonia, V.; et al. The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: A pilot study. Cancer Causes Control 2017, 28, 959–969. [Google Scholar] [CrossRef]
  29. Zhu, X.X.; Yang, X.J.; Chao, Y.L.; Zheng, H.M.; Sheng, H.F.; Liu, H.Y.; He, Y.; Zhou, H.W. The Potential Effect of Oral Microbiota in the Prediction of Mucositis during Radiotherapy for Nasopharyngeal Carcinoma. EBioMedicine 2017, 18, 23–31. [Google Scholar] [CrossRef] [Green Version]
  30. Chen, X.; Winckler, B.; Lu, M.; Cheng, H.; Yuan, Z.; Yang, Y.; Jin, L.; Ye, W. Oral Microbiota and Risk for Esophageal Squamous Cell Carcinoma in a High-Risk Area of China. PLoS ONE 2015, 10, e0143603. [Google Scholar] [CrossRef]
  31. Gaiser, R.A.; Halimi, A.; Alkharaan, H.; Lu, L.; Davanian, H.; Healy, K.; Hugerth, L.W.; Ateeb, Z.; Valente, R.; Fernández Moro, F.C.; et al. Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer. Gut 2019, 68, 2186–2194. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Nomura, Y.; Otsuka, R.; Hasegawa, R.; Hanada, N. Oral Microbiome of Children Living in an Isolated Area in Myanmar. Int. J. Environ. Res. Public Health 2020, 17, 4033. [Google Scholar] [CrossRef] [PubMed]
  33. Iwauchi, M.; Horigome, A.; Ishikawa, K.; Mikuni, A.; Nakano, M.; Xiao, J.Z.; Odamaki, T.; Hironaka, S. Relationship between oral and gut microbiota in elderly people. Immun. Inflamm. Dis. 2019, 7, 229–236. [Google Scholar] [CrossRef] [Green Version]
  34. Asakawa, M.; Takeshita, T.; Furuta, M.; Kageyama, S.; Takeuchi, K.; Hata, J.; Ninomiya, T.; Yamashita, Y. Tongue Microbiota and Oral Health Status in Community-Dwelling Elderly Adults. mSphere 2018, 3, e00332-18. [Google Scholar] [CrossRef] [Green Version]
  35. Hirotomi, T.; Yoshihara, A.; Ogawa, H.; Ito, K.; Igarashi, A.; Miyazaki, H. A preliminary study on the relationship between stimulated saliva and periodontal conditions in community-dwelling elderly people. J. Dent. 2006, 34, 692–698. [Google Scholar] [CrossRef] [PubMed]
  36. Yamaga, T.; Ogawa, H.; Miyazaki, H. Influence of occlusal deterioration considering prosthetics on subsequent all-cause mortality in a Japanese elderly independent population. Gerodontology 2019, 36, 163–170. [Google Scholar] [CrossRef] [PubMed]
  37. Nomura, Y.; Kakuta, E.; Okada, A.; Otsuka, R.; Shimada, M.; Tomizawa, Y.; Taguchi, C.; Arikawa, K.; Daikoku, H.; Sato, T.; et al. Oral microbiome in four female centenarians. Appl. Sci. 2020, 10, 5312. [Google Scholar] [CrossRef]
  38. Kim, O.S.; Cho, Y.J.; Lee, K.; Yoon, S.H.; Kim, M.; Na, H.; Park, S.C.; Jeon, Y.S.; Lee, J.H.; Yi, H.; et al. Introducing EzTaxon-e: A prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species. Int. J. Syst. Evol. Microbiol. 2012, 62, 716–721. [Google Scholar] [CrossRef]
  39. Yoon, S.H.; Ha, S.M.; Kwon, S.; Lim, J.; Kim, Y.; Seo, H.; Chun, J. Introducing EzBioCloud: A taxonomically united database of 16S rRNA and whole genome assemblies. Int. J. Syst. Evol. Microbiol. 2017, 67, 1613–1617. [Google Scholar] [CrossRef]
  40. Lahti, L.; Shetty, S. Introduction to the Microbiome R Package. 2020. Available online: https://microbiome.github.io/tutorials/ (accessed on 31 August 2020).
  41. Shetty, S.A.; Hugenholtz, F.; Lahti, L.; Smidt, H.; de Vos, W.M. Intestinal microbiome landscaping: Insight in community assemblage and implications for microbial modulation strategies. FEMS Microbiol. Rev. 2017, 41, 182–199. [Google Scholar] [CrossRef]
  42. Bagwell, C.B. High-Dimensional Modeling for Cytometry: Building Rock Solid Models Using GemStone™ and Verity Cen-se’™ High-Definition t-SNE Mapping. Methods Mol. Biol. 2018, 1678, 11–36. [Google Scholar] [CrossRef]
  43. Jiang, Q.; Liu, J.; Chen, L.; Gan, N.; Yang, D. The Oral Microbiome in the Elderly with Dental Caries and Health. Front. Cell. Infect. Microbiol. 2019, 8, 442. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Balle, C.; Esra, R.; Havyarimana, E.; Jaumdally, S.Z.; Lennard, K.; Konstantinus, I.N.; Barnabas, S.L.; Happel, A.U.; Gill, K.; Pidwell, T.; et al. Relationship between the Oral and Vaginal Microbiota of South African Adolescents with High Prevalence of Bacterial Vaginosis. Microorganisms 2020, 8, 1004. [Google Scholar] [CrossRef]
  45. Matsha, T.E.; Prince, Y.; Davids, S.; Chikte, U.; Erasmus, R.T.; Kengne, A.P.; Davison, G.M. Oral Microbiome Signatures in Diabetes Mellitus and Periodontal Disease. J. Dent. Res. 2020, 99, 658–665. [Google Scholar] [CrossRef]
  46. Burcham, Z.M.; Garneau, N.L.; Comstock, S.S.; Tucke, R.M.; Knight, R.; Metcalf, J.L. Patterns of Oral Microbiota Diversity in Adults and Children: A Crowdsourced Population Study. Sci. Rep. 2020, 10, 2133. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Nakano, M.; Wakabayashi, H.; Sugahara, H.; Odamaki, T.; Yamauchi, K.; Abe, F.; Xiao, J.Z.; Murakami, K.; Ishikawa, K.; Hironaka, S. Effects of lactoferrin and lactoperoxidase-containing food on the oral microbiota of older individuals. Microbiol. Immunol. 2017, 61, 416–426. [Google Scholar] [CrossRef] [Green Version]
  48. Anderson, A.C.; Rothballer, M.; Altenburger, M.J.; Woelber, J.P.; Karygianni, L.; Vach, K.; Hellwig, E.; Al-Ahmad, A. Long-term fluctuation of oral biofilm microbiota following different dietary phases. Appl. Environ. Microbiol. 2020. [Google Scholar] [CrossRef]
  49. Sampaio-Maia, B.; Monteiro-Silva, F. Acquisition and maturation of oral microbiome throughout childhood: An update. Dent. Res. J. 2014, 11, 291–301. [Google Scholar]
  50. Anderson, A.C.; Rothballer, M.; Altenburger, M.J.; Woelber, J.P.; Karygianni, L.; Lagkouvardos, I.; Hellwig, E.; Al-Ahmad, A. In-vivo shift of the microbiota in oral biofilm in response to frequent sucrose consumption. Sci. Rep. 2018, 8, 14202. [Google Scholar] [CrossRef]
  51. Yang, L.; Dunlap, D.G.; Qin, S.; Fitch, A.; Li, K.; Koch, C.D.; Nouraie, M.; DeSensi, R.; Ho, K.S.; Martinson, J.J.; et al. Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function. Am. J. Respir. Crit. Care Med. 2020, 201, 445–457. [Google Scholar] [CrossRef]
  52. Starr, J.R.; Huang, Y.; Lee, K.H.; Murphy, C.M.; Moscicki, A.B.; Shiboski, C.H.; Ryder, M.I.; Yao, T.J.; Faller, L.L.; Dyke, V.R.B.; et al. Oral microbiota in youth with perinatally acquired HIV infection. Microbiome 2018, 6, 100. [Google Scholar] [CrossRef] [PubMed]
  53. Anbalagan, R.; Srikanth, P.; Mani, M.; Barani, R.; Seshadri, K.G.; Janarthanan, R. Next generation sequencing of oral microbiota in Type 2 diabetes mellitus prior to and after neem stick usage and correlation with serum monocyte chemoattractant-1. Diabetes Res. Clin. Pract. 2017, 130, 204–210. [Google Scholar] [CrossRef] [PubMed]
  54. Querido, N.B.; de Araujo, W.C. Selective isolation of Neisseria sicca from the human oral cavity on eosin methylene blue agar. Appl. Environ. Microbiol. 1976, 4, 612–614. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Cephas, K.D.; Kim, J.; Mathai, R.A.; Barry, K.A.; Dowd, S.E.; Meline, B.S.; Swanson, K.S. Comparative analysis of salivary bacterial microbiome diversity in edentulous infants and their mothers or primary care givers using pyrosequencing. PLoS ONE 2011, 6, e23503. [Google Scholar] [CrossRef]
  56. Shi, W.; Qin, M.; Chen, F.; Xia, B. Supragingival Microbial Profiles of Permanent and Deciduous Teeth in Children with Mixed Dentition. PLoS ONE 2016, 11, e0146938. [Google Scholar] [CrossRef] [Green Version]
  57. Lassalle, F.; Spagnoletti, M.; Fumagalli, M.; Shaw, L.; Dyble, M.; Walker, C.; Thomas, M.G.; Migliano, A.B.; Balloux, F. Oral microbiomes from hunter-gatherers and traditional farmers reveal shifts in commensal balance and pathogen load linked to diet. Mol. Ecol. 2018, 27, 182–195. [Google Scholar] [CrossRef] [Green Version]
  58. Ruiz, L.; Bacigalupe, R.; García-Carral, C.; Boix-Amoros, A.; Argüello, H.; Silva, C.B.; de los Angeles Checa, M.; Mira, A.; Rodríguez, J. Microbiota of human precolostrum and its potential role as a source of bacteria to the infant mouth. Sci. Rep. 2019, 9, 8435. [Google Scholar] [CrossRef] [Green Version]
  59. Biagi, E.; Aceti, A.; Quercia, S.; Beghetti, I.; Rampelli, S.; Turroni, S.; Soverini, M.; Zambrini, A.V.; Faldella, G.; Candela, M.; et al. Microbial Community Dynamics in Mother’s Milk and Infant’s Mouth and Gut in Moderately Preterm Infants. Front. Microbiol. 2018, 22, 2512. [Google Scholar] [CrossRef] [Green Version]
  60. Bidossi, A.; de Grandi, R.; Toscano, M.; Bottagisio, M.; de Vecchi, E.; Gelardi, M.; Drago, L. Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract. BMC Infect. Dis. 2018, 18, 653. [Google Scholar] [CrossRef]
  61. Humphreys, G.J.; McBain, A.J. Antagonistic effects of Streptococcus and Lactobacillus probiotics in pharyngeal biofilms. Lett. Appl. Microbiol. 2019, 68, 303–312. [Google Scholar] [CrossRef]
  62. Woo, P.C.; Teng, J.L.; Leung, K.W.; Lau, S.K.; Tse, H.; Wong, B.H.; Yuen, K.Y. Streptococcus sinensis may react with Lancefield group F antiserum. J. Med. Microbiol. 2004, 53, 1083–1088. [Google Scholar] [CrossRef] [PubMed]
  63. Faibis, F.; Mihaila, L.; Perna, S.; Lefort, J.F.; Demachy, M.C.; le Flèche-Matéos, A.; Bouvet, A. Streptococcus sinensis: An emerging agent of infective endocarditis. J. Med. Microbiol. 2008, 57, 528–531. [Google Scholar] [CrossRef] [PubMed]
  64. Leonard, A.; Lalk, M. Infection and metabolism—Streptococcus pneumoniae metabolism facing the host environment. Cytokine 2018, 112, 75–86. [Google Scholar] [CrossRef] [PubMed]
  65. Valm, A.M.; Welch, J.L.; Rieken, C.W.; Hasegawa, Y.; Sogin, M.L.; Oldenbourg, R.; Dewhirst, F.E.; Borisy, G.G. Systems-level analysis of microbial community organization through combinatorial labeling and spectral imaging. Proc. Natl. Acad. Sci. USA 2011, 108, 4152–4157. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Zaura, E.; Keijser, B.J.; Huse, S.M.; Crielaard, W. Defining the healthy “core microbiome” of oral microbial communities. BMC Microbiol. 2009, 9, 259. [Google Scholar] [CrossRef] [Green Version]
  67. Kanasi, E.; Dewhirst, F.E.; Chalmers, N.I.; Kent, R., Jr.; Moore, A.; Hughes, C.V.; Pradhan, N.; Loo, C.Y.; Tanner, A.C.R. Clonal analysis of the microbiota of severe early childhood caries. Caries Res. 2010, 44, 485–497. [Google Scholar] [CrossRef] [Green Version]
  68. Khemaleelaku, S.; Baumgartner, J.C.; Pruksakorn, S. Identification of bacteria in acute endodontic infections and their antimicrobial susceptibility. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2002, 94, 746–755. [Google Scholar] [CrossRef]
  69. Mashima, I.; Kamaguchi, A.; Nakazawa, F. The distribution and frequency of oral veillonella spp. in the tongue biofilm of healthy young adults. Curr. Microbiol. 2011, 63, 403–407. [Google Scholar] [CrossRef]
  70. Kolenbrander, P.E. Oral microbial communities: Biofilms, interactions, and genetic systems. Annu. Rev. Microbiol. 2000, 54, 413–437. [Google Scholar] [CrossRef]
  71. Aas, J.A.; Paster, B.J.; Stokes, L.N.; Olsen, I.; Dewhirst, F.E. Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 2005, 43, 5721–5732. [Google Scholar] [CrossRef] [Green Version]
  72. Jensen, E.; Allen, G.; Bednarz, J.; Couper, J.; Peña, A. Periodontal risk markers in children and adolescents with type 1 diabetes: A systematic review and meta-analysis. Diabetes Metab. Res. Rev. 2020, e3368. [Google Scholar] [CrossRef]
  73. Wang, J.; Yang, X.; Zou, X.; Zhang, Y.; Wang, J.; Wang, Y. Relationship between periodontal disease and lung cancer: A systematic review and meta-analysis. J. Periodontal. Res. 2020. [Google Scholar] [CrossRef] [PubMed]
  74. Nadim, R.; Tang, J.; Dilmohamed, A.; Yuan, S.; Wu, C.; Bakre, A.T.; Partridge, M.; Ni, J.; Copeland, J.R.; Anstey, K.J.; et al. Influence of periodontal disease on risk of dementia: A systematic literature review and a meta-analysis. Eur. J. Epidemiol. 2020. [Google Scholar] [CrossRef]
  75. Priyamvara, A.; Dey, A.K.; Bandyopadhyay, D.; Katikineni, V.; Zaghlol, R.; Basyal, B.; Barssoum, K.; Amarin, R.; Bhatt, D.L.; Lavie, C.J. Periodontal Inflammation and the Risk of Cardiovascular Disease. Curr. Atheroscler. Rep. 2020, 22, 28. [Google Scholar] [CrossRef]
  76. Orlandi, M.; Graziani, F.; D’Aiuto, F. Periodontal therapy and cardiovascular risk. Periodontol. 2000 2020, 83, 107–124. [Google Scholar] [CrossRef]
  77. Jepsen, S.; Suvan, J.; Deschner, J. The association of periodontal diseases with metabolic syndrome and obesity. Periodontol. 2000 2020, 83, 125–153. [Google Scholar] [CrossRef]
  78. Isola, G.; Polizzi, A.; Iorio-Siciliano, V.; Alibrandi, A.; Ramaglia, L.; Leonardi, R. Effectiveness of a nutraceutical agent in the non-surgical periodontal therapy: A randomized, controlled clinical trial. Clin. Oral Investig. 2020, 1–11. [Google Scholar] [CrossRef]
  79. Isola, G.; Polizzi, A.; Santonocito, S.; Alibrandi, A.; Ferlito, S. Expression of Salivary and Serum Malondialdehyde and Lipid Profile of Patients with Periodontitis and Coronary Heart Disease. Int. J. Mol. Sci. 2019, 20, 6061. [Google Scholar] [CrossRef] [Green Version]
  80. Isola, G.; Giudice, A.L.; Polizzi, A.; Alibrandi, A.; Patini, R.; Ferlito, S. Periodontitis and Tooth Loss Have Negative Systemic Impact on Circulating Progenitor Cell Levels: A Clinical Study. Genes 2019, 10, 1022. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Microbiome structure in saliva: (A) phylum level; (B) genus level.
Figure 1. Microbiome structure in saliva: (A) phylum level; (B) genus level.
Applsci 10 06450 g001
Figure 2. Overview of operational-taxonomic-unit (OTU) prevalence and taxonomic affiliations.
Figure 2. Overview of operational-taxonomic-unit (OTU) prevalence and taxonomic affiliations.
Applsci 10 06450 g002
Figure 3. Core visualization: (A) phylogenetic tree and (B) core heatmap of 13 species detected in all subjects.
Figure 3. Core visualization: (A) phylogenetic tree and (B) core heatmap of 13 species detected in all subjects.
Applsci 10 06450 g003
Figure 4. Ordination analysis as a function of t-distributed stochastic neighbor embedding (t-SNE) plot categorized by (A) prevalence and (B) genus.
Figure 4. Ordination analysis as a function of t-distributed stochastic neighbor embedding (t-SNE) plot categorized by (A) prevalence and (B) genus.
Applsci 10 06450 g004
Table 1. Bacterial species detected in more than 90% of subjects.
Table 1. Bacterial species detected in more than 90% of subjects.
TaxonomyPrevalence
(n%)
Abundance (Average)
PhylumGenusSpecies
100%FirmicutesStreptococcusStreptococcus sinensis85/85100%10.14%
FirmicutesStreptococcusStreptococcus pneumoniae85/85100%9.61%
FirmicutesStreptococcusStreptococcus salivarius85/85100%8.75%
ActinobacteriaRothiaKV831974_s85/85100%8.30%
FirmicutesStreptococcusStreptococcus parasanguinis85/85100%6.13%
FirmicutesVeillonellaVeillonella dispar85/85100%4.31%
FirmicutesGranulicatellaGranulicatella adiacens85/85100%2.90%
FirmicutesStreptococcusStreptococcus_uc85/85100%2.80%
FirmicutesStreptococcusStreptococcus peroris85/85100%2.67%
ActinobacteriaActinomycesKE952139_s85/85100%1.72%
FirmicutesVeillonellaVeillonella parvula85/85100%1.15%
ActinobacteriaAtopobiumAtopobium parvulum85/85100%0.89%
FirmicutesStreptococcusAFQU_s85/85100%0.77%
99%–95%FirmicutesVeillonellaVeillonella atypica84/8598.8%2.22%
ActinobacteriaActinomycesActinomyces_uc84/8598.8%0.30%
FirmicutesVeillonellaVeillonella_uc84/8598.8%0.25%
ActinobacteriaRothiaRothia mucilaginosa83/8597.6%5.43%
FirmicutesGemellaGemella haemolysans83/8597.6%1.23%
ActinobacteriaRothiaRothia_uc83/8597.6%0.28%
ProteobacteriaCampylobacterCampylobacter concisus83/8597.6%0.10%
BacteroidesPrevotellaPrevotella melaninogenica82/8596.5%2.92%
FirmicutesStreptococcusStreptococcus gordonii82/8596.5%1.78%
FirmicutesMoryellaStomatobaculum longum82/8596.5%0.31%
ActinobacteriaActinomycesJVLH_s82/8596.5%0.18%
ActinobacteriaRothiaRothia dentocariosa81/8595.3%1.36%
FirmicutesBulleidiaSolobacterium moorei81/8595.3%0.20%
>90%FusobacteriaFusobacteriumFusobacterium nucleatum80/8594.1%0.87%
FirmicutesMegasphaeraMegasphaera micronuciformis80/8594.1%0.30%
ActinobacteriaActinomycesActinomyces odontolyticus80/8594.1%0.24%
FirmicutesLachnoanaerobaculumLachnoanaerobaculum saburreum80/8594.1%0.17%
BacteroidesPrevotellaPrevotella histicola79/8592.9%2.39%
ProteobacteriaHaemophilusHaemophilus parainfluenzae79/8592.9%0.88%
BacteroidesPrevotellaPrevotella_uc79/8592.9%0.42%
FirmicutesStreptococcusStreptococcus sanguinis78/8591.8%0.92%
ActinobacteriaActinomycesActinomyces graevenitzii78/8591.8%0.52%
BacteroidesPrevotellaPrevotella salivae77/8590.6%0.25%
FirmicutesOribacteriumOribacterium asaccharolyticum77/8590.6%0.24%

Share and Cite

MDPI and ACS Style

Nomura, Y.; Kakuta, E.; Kaneko, N.; Nohno, K.; Yoshihara, A.; Hanada, N. The Oral Microbiome of Healthy Japanese People at the Age of 90. Appl. Sci. 2020, 10, 6450. https://doi.org/10.3390/app10186450

AMA Style

Nomura Y, Kakuta E, Kaneko N, Nohno K, Yoshihara A, Hanada N. The Oral Microbiome of Healthy Japanese People at the Age of 90. Applied Sciences. 2020; 10(18):6450. https://doi.org/10.3390/app10186450

Chicago/Turabian Style

Nomura, Yoshiaki, Erika Kakuta, Noboru Kaneko, Kaname Nohno, Akihiro Yoshihara, and Nobuhiro Hanada. 2020. "The Oral Microbiome of Healthy Japanese People at the Age of 90" Applied Sciences 10, no. 18: 6450. https://doi.org/10.3390/app10186450

APA Style

Nomura, Y., Kakuta, E., Kaneko, N., Nohno, K., Yoshihara, A., & Hanada, N. (2020). The Oral Microbiome of Healthy Japanese People at the Age of 90. Applied Sciences, 10(18), 6450. https://doi.org/10.3390/app10186450

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop